Atlas Trials

Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)

Clinical trial NCT06193928 · RECRUITING

Trial details

NCT number
NCT06193928
Sponsor
Mirum Pharmaceuticals, Inc.
Status
RECRUITING
Study type
OBSERVATIONAL
Alagille SyndromeProgressive Familial Intrahepatic Cholestasis
Start date
2023-09-21
Primary completion
2028-09-20
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.